Abstract
Objective: The standard treatment for early-stage high-risk endometrial cancer is whole-pelvis radiation. Although whole-pelvis radiation reduces recurrences by reducing pelvic failures, it does not improve survival. In this study, we report our experience of treating early-stage high-risk endometrial cancer with vaginal brachytherapy (VB) and chemotherapy and compare the results with those of GOG-99.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
